Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 5Terminated 2Unknown 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 299Solid Tumors 184Advanced Solid Tumors 168Solid Tumor 152Mesothelioma, Malignant 152Mesothelioma 121Advanced Solid Tumor 97Carcinoma, Non-Small-Cell Lung 50Retinoblastoma 48Lung Neoplasms 37Solid Tumor, Adult 36Sarcoma 31Ovarian Neoplasms 29Neoplasms 27Stomach Neoplasms 26Carcinoma, Renal Cell 26Small Cell Lung Carcinoma 25Melanoma 25Pancreatic Neoplasms 24Breast Neoplasms 24Unspecified Childhood Solid Tumor, Protocol Specific 23Esophageal Neoplasms 21Uterine Cervical Neoplasms 20Solid Tumours 20Solitary Fibrous Tumor, Pleural 19Osteosarcoma 19Colorectal Neoplasms 17Neuroblastoma 16Head and Neck Neoplasms 16Carcinoma, Hepatocellular 16

Interventions

capivasertib 1N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 1Midazolam 1L19-IL2 immunocytokine 1Itraconazole 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Solid Tumour × Other solid neoplasm × Clear all
NCT04958226 2024-01-25

A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Completed
21 enrolled
Other solid neoplasm

Solid Tumour

NCT04121910 2020-01-23

A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole

AstraZeneca

Phase 1 Completed
16 enrolled
Other solid neoplasm

Solid Tumour

NCT02086721 2017-05-31

L19-IL2

Maastricht Radiation Oncology

Phase 1 Completed
18 enrolled
Other solid neoplasm

Solid Tumour

NCT01627990 2015-07-24

Nivestimâ„¢ in Treatment of Malignant Diseases

Hospira, now a wholly owned subsidiary of Pfizer

Completed
386 enrolled
Other solid neoplasm

Solid Tumour

NCT01300468 2011-02-21

Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors

Nerviano Medical Sciences

Phase 1 Completed
38 enrolled
Other solid neoplasm

Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡